Charité - Universitätsmedizin Berlin

Tomoelastography distinguishes noninvasively between benign and malignant liver lesions (2019) Shahryari M, Tzschaetzsch H, Garcia SRM, Boening G, Fehrenbach U, Stencel L, Asbach P, et al. Journal article Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) House AA, Wanner C, Sarnak MJ, Pina IL, Mcintyre CW, Komenda P, Kasiske BL, et al. Journal article S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2. (2019) Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Foelster-Holst R, Gerdes S, et al. Journal article Update Breast Cancer 2019 Part 5 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer. (2019) Welslau M, Hartkopf AD, Mueller V, Woeckel A, Lux MP, Janni W, Ettl J, et al. Journal article, Review article S3-Leitlinie: Durchführung des Epikutantests mit Kontaktallergenen und Arzneimitteln - Kurzfassung Teil 2. (2019) Mahler V, Nast A, Bauer A, Becker D, Brasch J, Breuer K, Dickel H, et al. Journal article An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients. (2019) Sommerer C, Suwelack B, Dragun D, Schenker P, Hauser IA, Witzke O, Hugo C, et al. Journal article Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome. (2019) Anthony LB, Kulke MH, Caplin ME, Bergsland E, Oberg K, Pavel M, Hoersch D, et al. Journal article The relevance of cancer related fatigue in neuroendocrine neoplasia patients (2019) Banz S, Mellar K, Letsch A, Scheibenbogen C, Pavel ME, Grabowski P Conference contribution Systemic Anti-Cancer Therapies Impair the Nutritional Status of Neuroendocrine Tumor Patients (2019) Pevny S, Maasberg S, Karber M, Knappe-Drzikova B, Weylandt KH, Jann H, Pavel ME, et al. Conference contribution Comparison of guidelines for the management of patients with high-risk and advanced cutaneous squamous cell carcinoma - a systematic review (2019) Heppt MV, Steeb T, Berking C, Nast A Journal article